We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
176
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$154M 0.1%
4,515,954
-106,120
-2% -$3.64M
TTE icon
177
TotalEnergies
TTE
$190B
$154M 0.1%
2,307,069
-228,807
-9% -$16.3M
KMB icon
178
Kimberly-Clark
KMB
$36.5B
$151M 0.1%
1,090,624
-324,461
-23% -$43.3M
IVE icon
179
iShares S&P 500 Value ETF
IVE
$49.8B
$149M 0.1%
820,957
+40,359
+5% +$7.35M
RSG icon
180
Republic Services
RSG
$65.7B
$146M 0.1%
749,448
+22,453
+3% +$4.24M
VRTX icon
181
Vertex Pharmaceuticals
VRTX
$126B
$146M 0.1%
310,646
-8,111
-3% -$3.52M
ELV icon
182
Elevance Health
ELV
$85.5B
$146M 0.1%
268,561
+4,756
+2% +$2.51M
DGRO icon
183
iShares Core Dividend Growth ETF
DGRO
$43.5B
$144M 0.09%
2,493,415
+22,785
+0.9% +$1.3M
INTC icon
184
Intel
INTC
$513B
$143M 0.09%
4,612,269
-431,276
-9% -$14.1M
TFC icon
185
Truist Financial
TFC
$64B
$141M 0.09%
3,634,706
-75,292
-2% -$2.84M
BDX icon
186
Becton Dickinson
BDX
$48.2B
$140M 0.09%
600,248
-5,036
-0.8% -$1.19M
HAL icon
187
Halliburton
HAL
$26.6B
$140M 0.09%
4,142,431
+183,429
+5% +$6.77M
IEI icon
188
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$140M 0.09%
1,211,223
-22,649
-2% -$2.6M
ZTS icon
189
Zoetis
ZTS
$30B
$138M 0.09%
794,419
+45,597
+6% +$7.59M
JEPI icon
190
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
$137M 0.09%
2,421,638
+439,155
+22% +$24.8M
USFR icon
191
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$136M 0.09%
2,709,022
+727,393
+37% +$36.7M
FDX icon
192
FedEx
FDX
$75.4B
$136M 0.09%
454,457
-3,061
-0.7% -$801K
ISRG icon
193
Intuitive Surgical
ISRG
$134B
$135M 0.09%
303,767
-22,528
-7% -$8.97M
UBER icon
194
Uber
UBER
$153B
$135M 0.09%
1,859,244
-810,094
-30% -$56.3M
CVS icon
195
CVS Health
CVS
$122B
$135M 0.09%
2,286,472
-372,541
-14% -$23.3M
UL icon
196
Unilever
UL
$136B
$134M 0.09%
2,173,695
-288,356
-12% -$17M
BMY icon
197
Bristol-Myers Squibb
BMY
$132B
$132M 0.09%
3,187,027
-196,522
-6% -$8.79M
SNPS icon
198
Synopsys
SNPS
$79.7B
$132M 0.09%
222,058
+48,552
+28% +$27.5M
USB icon
199
US Bancorp
USB
$99.6B
$132M 0.09%
3,324,877
-166,948
-5% -$6.81M
EQIX icon
200
Equinix
EQIX
$103B
$131M 0.09%
172,904
+5,056
+3% +$3.84M

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.